Welcome to Probiodrug
Pioneering Therapeutics for Common Degenerative Disorders
Probiodrug AG is a biopharmaceutical company focused on the development of innovative oral drugs for the treatment of major age related diseases.
The Company has successfully pioneered the development of therapeutics to treat diabetes and is now applying its expertise to develop new drugs for the convenient and efficient treatment of other disorders that belong to the world’s most widespread diseases, including pain/inflammation and neurodegenerative diseases such as Alzheimer’s disease.
Latest News
2009-11-02
Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) … more
2009-07-11
Probiodrug to Present an Update on QC Inhibition as Potential New Treatment for Alzheimer's Disease at the International Conference on Alzheimer Disease - ICAD - 2009 in Vienna, Austria, July 11-16 … more
2009-05-15
Probiodrug Announces Validity of European Patent Covering Use of DP4 inhibitors for the Treatment of Anxiety … more